Genetic Susceptibility to Ovarian Cancer Does Not Modify Protective Effect of Aspirin
TUESDAY, March 7, 2023 (HealthDay News) -- Genetic susceptibility to ovarian cancer does not modify the protective effect of frequent aspirin use on ovarian cancer risk, according to a study published online Feb. 24 in JAMA Network Open.
Lauren M. Hurwitz, Ph.D., from the National Cancer Institute in Rockville, Maryland, and colleagues examined whether the association between frequent aspirin use and ovarian cancer is modified by a polygenic score (PGS) for nonmucinous ovarian cancer. Individual-level data were pooled from eight case-control studies between 1995 and 2009. Case and control participants with genetic data and data on aspirin use were included in the study; the analysis included 4,476 case patients with nonmucinous ovarian cancer and 6,659 control participants.
Overall, 13 and 15 percent of case patients and control participants, respectively, reported frequent aspirin use. The researchers found that PGS did not modify the 13 percent reduction in ovarian cancer risk (odds ratio, 0.87). Among individuals with a PGS less than and greater than the median, consistent odds ratios were observed. Similar results were seen by histotype.
"Frequent aspirin use reduces the risk of nonmucinous ovarian cancer -- including high-grade serous and endometrioid ovarian cancer -- across most strata of genetic risk based on a PGS, including among individuals with a PGS greater than the median," the authors write.
Several authors disclosed financial ties to the biopharmaceutical industry.
Related Posts
Your Doctor’s Gender, Race May Bias Your Treatment Outcome
TUESDAY, June 28, 2022 (HealthDay News) -- Deep-rooted bias may affect the way...
E-Cigarette Use Tied to Excess Health Care Utilization
TUESDAY, May 24, 2022 (HealthDay News) -- Adult current electronic cigarette use...
COVID-19 Proning Teams Benefit From Wound Care Specialist Nurse
THURSDAY, Jan. 20, 2022 (HealthDay News) -- The inclusion of a certified wound...
Many Who Need Opioid OD Antidote the Most Can’t Afford It
MONDAY, Aug. 22, 2022 (HealthDay News) -- Naloxone is a lifesaving antidote to...